Vidyasrilekha Yele (Vidyasrilekha Sanapalli)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Epithelial Mesenchymal Transition

Candida Albicans

Silver Nanoparticles

Top Venues

Antibiotics (Basel, Switzerland)

Diseases (Basel, Switzerland)

Assay and drug development technologies

This page only lists publications with an associated author ORCID identifier.

Publications

Ragib Ahsan, Sumaiya Kifayat, Krishan Kumar Pooniya, Sunita Kularia, Bhavani Sailu Adimalla, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Bharat Kumar Reddy Sanapalli, Ashwini S Deshpande, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. Diseases (Basel, Switzerland) 12 (8) (2024)
Ragib Ahsan, Sumaiya Kifayat, Krishan Kumar Pooniya, Sunita Kularia, Bhavani Sailu Adimalla, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Bharat Kumar Reddy Sanapalli, Ashwini S Deshpande, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. Diseases (Basel, Switzerland) 12 (8) (2024)
Ragib Ahsan, Sumaiya Kifayat, Krishan Kumar Pooniya, Sunita Kularia, Bhavani Sailu Adimalla, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Bacterial Histidine Kinase and the Development of Its Inhibitors in the 21st Century. Antibiotics (Basel, Switzerland) 13 (7) (2024)
Bharat Kumar Reddy Sanapalli, Ashwini S Deshpande, Vidyasrilekha Yele, Dilep Kumar Sigalapalli
Unveiling the Unexplored Multifactorial Potential of 5-Aminosalicylic Acid in Diabetic Wound Therapy. Diseases (Basel, Switzerland) 12 (8) (2024)
Sumaiya Kifayat, Vidyasrilekha Yele, Akram Ashames, Dilep Kumar Sigalapalli, Richie R Bhandare, Afzal Basha Shaik, Venkatarathnam Nasipireddy, Bharat Kumar Reddy Sanapalli
Filamentous temperature sensitive mutant Z: a putative target to combat antibacterial resistance. RSC advances 13 (17) (2023)
Bharat Kumar Reddy Sanapalli, Akram Ashames, Dilep Kumar Sigalapalli, Afzal Basha Shaik, Richie R Bhandare, Vidyasrilekha Yele
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Bharat Kumar Reddy Sanapalli, Akram Ashames, Dilep Kumar Sigalapalli, Afzal Basha Shaik, Richie R Bhandare, Vidyasrilekha Yele
Synthetic Imidazopyridine-Based Derivatives as Potential Inhibitors against Multi-Drug Resistant Bacterial Infections: A Review. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Hitesh Jamod, Kajal Mehta, Arpit Sakariya, Shweta Shoukani, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele
Dual Acting Immuno-Antibiotics: Computational Investigation on Antibacterial Efficacy of Immune Boosters Against Isoprenoid H Enzyme. Assay and drug development technologies 20 (5) (2022)
Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele, Srikanth Jupudi, Veera Venkata Satyanarayana Reddy Karri
Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors. RSC advances 11 (43) (2021)
Vidyasrilekha Yele, Bharat Kumar Reddy Sanapalli, Afzal Azam Mohammed
Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach. Chemicke zvesti (2021)